Related Experiment Videos

[Advances in hypertension and diabetes]

Pilar Mazón-Ramos1, Alberto Cordero-Fort, Juan Quiles-Granado

  • 1Servicio de Cardiología, Hospital Clínico Universitario, Santiago de Compostela, A Coruña, España. pilarmazon@yahoo.es

Revista Espanola De Cardiologia
|January 29, 2009
PubMed

Insights

Recent clinical trials offer new insights into managing cardiovascular disease risk factors in hypertensive and diabetic patients. Findings prompt discussions on optimal blood pressure and blood glucose targets and new hypertension treatments.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Trials

Background:

  • Cardiovascular disease (CVD) management in hypertensive and diabetic patients is critical.
  • Recent clinical trials have yielded significant, sometimes unexpected, results.
  • Established treatment guidelines are being re-evaluated based on new evidence.

Purpose of the Study:

  • To review recent clinical trial findings on CVD risk factor management.
  • To discuss the optimal reduction targets for blood pressure and glycemia in CVD patients.
  • To summarize new therapeutic approaches for hypertension.

Main Methods:

  • Review of recently published clinical trials.
  • Analysis of observational studies from the Spanish Society of Cardiology's working group on hypertension.
  • Synthesis of current evidence on hypertension and diabetes management.

Main Results:

  • New data confirm some existing knowledge on risk factor control.
  • Unexpected findings have spurred debate on target blood pressure and glycemia levels.
  • Updated information on novel antihypertensive drugs and combinations is available.

Conclusions:

  • Recent trials necessitate a re-evaluation of CVD risk factor reduction targets.
  • New pharmacological options for hypertension management have emerged.
  • Ongoing research and observational data continue to refine clinical practice for hypertensive and diabetic patients.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...